Spire by St Brides

Alan Green talks to Frank Lewis

Accomplished Non-Executive, Executive Director and Chairman Frank Lewis talks through his experiences and his many roles working in different sectors with various AIM and private companies over the years. Frank provides advice and guidance to companies trying to navigate their way through the current COVID-19 crisis, and provides some key takeaway points and ‘golden rules’ […]

Open Orphan #ORPH – Positive Phase 1 study results published in The Lancet

Monday 15th June, 2020 Positive results from the Phase I study of the AGS-v vaccine developed by an Open Orphan joint venture, Imutex Limited, have been published in the peer reviewed journal The Lancet AGS-v is a first-in-class mosquito saliva, standalone, vaccine candidate designed to protect against mosquito-borne diseases carried in the saliva such as Zika, Malaria, […]

Experts seek approval for COVID-19 trials – China Daily

By ANGUS McNEICE in London Medical community divided on issue of exposing humans to deadly virus A laboratory in the United Kingdom is hoping to become the first in the world to intentionally infect volunteers with novel coronavirus in order to test the efficacy of COVID-19 vaccines. Half of the participants in these so-called human […]

FT Article – China turns to steel to galvanise post-Covid economy

Thomas Hale in Hong Kong and Neil Hume in London The coronavirus pandemic is putting China on course to dominate global steel production to an even greater extent than before, accelerating a trend that has gathered pace for more than half a century. In April, a locked-down UK produced less than half of 1 per […]

Open Orphan #ORPH – Major New Contract Win for Venn Life Sciences

Open Orphan plc (ORPH) a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, is pleased to announce that it has signed a major contract with a leading vaccine developer and one of the top pharmaceutical companies in the world. […]

Venture Life Group (AIM: VLG) – Alan Green talks to CEO Jerry Randall

Alan Green talks Jerry Randall, CEO of Venture Life Group (AIM: VLG). Jerry provides an overview of the company operating structure and strategy, and then covers today’s trading statement, going into detail on the very strong trading that will see the company ‘comfortably exceed market expectations’ for the year. Jerry covers the group’s commercial relationships […]

Cadence Minerals #KDNC – Alan Green interviews CEO Kiran Morzaria, plus shareholder Q&A

Alan Green talks to Cadence Minerals #KDNC CEO Kiran Morzaria. Kiran talks about the company’s investments into the Czech Cinovec Lithium project via European Metals #EMH, Macarthur Minerals iron ore projects in Australia, plus Lithium JV’s with Bacanora in Mexico and Hastings Tech Metals at Yangibana, Australia. Kiran then elaborates on the company’s flagship Amapa […]

Union Jack Oil (AIM: UJO) – Alan Green talks to Executive Chairman David Bramhill

Alan Green talks to David Bramhill, Executive Chairman at Union Jack Oil (AIM: UJO), a company engaged in onshore hydrocarbon production and development in the UK. David discusses key projects including Wressle and the additional stake acquisition which takes the UJO stake to 45.5%. He also discusses West Newton and Biscathorpe, and with over £5m […]